Through
4/26
T cells, which are among the most powerful weapons in the immune systems of humans and other vertebrates, remain substantially programmed to stay exhausted even many weeks after exposure to a virus ended.
Richard Phillips, a Presidential Assistant Professor of Neurology and member of the Penn Epigenetics Institute, hopes to bring glioma research out of the “basement.”
The low-cost biosensor test developed by Penn Medicine could extend COVID-19 testing with 90% accuracy to remote and disadvantaged areas.
Penn scientists use cryo-electron microscopy to illuminate how a chemical compound found in the plant, piperlongumine, works against glioblastoma.
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, therefore only a single dose may be needed to produce a sufficient antibody response, according to new research from the Penn Institute of Immunology.
This year, 147 medical students from the Perelman School of Medicine celebrated the reveal of their residency placements on Match Day in hybrid celebration of virtual and small number of in-person students.
Research from Penn Medicine shows brain responses and attitudes reinforce the “anomalous is bad” stereotype.
The Interventional Support Center, an instrument processing and surgical supply preparation facility, will support two hospitals and three outpatient centers.
Rachel Talley on public psychiatry, the impact of COVID-19 on community mental health, and how she went from an internship at the White House to championing public health at Penn’s department of Psychiatry.
The new installation from the renowned artist and designer embodies the health system’s goal of creating calming, healing environments for patients.